Clinical Trials Browser

Phase 2 × INDUSTRY × denileukin diftitox × Clear all

NCT01127451 2022-04-13

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Phase 2 Completed

75 enrolled 15 charts

Melanoma, Neoplasms

NCT00211185 2020-03-18

A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma

Phase 2 Completed

49 enrolled 11 charts

Lymphoma, T-Cell, Peripheral

NCT00051025 2012-07-13

Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)

Phase 2 Completed

9 enrolled 10 charts

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT00211276 2012-03-14

A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma

Phase 2 Completed

Lymphoma, B-Cell

NCT00055146 2009-04-17

Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell